Giulia Sorgentoni

591 total citations
16 papers, 268 citations indexed

About

Giulia Sorgentoni is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Giulia Sorgentoni has authored 16 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Giulia Sorgentoni's work include Mesenchymal stem cell research (3 papers), Cancer Cells and Metastasis (3 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Giulia Sorgentoni is often cited by papers focused on Mesenchymal stem cell research (3 papers), Cancer Cells and Metastasis (3 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Giulia Sorgentoni collaborates with scholars based in Italy, United States and Spain. Giulia Sorgentoni's co-authors include Monia Orciani, Roberto Di Primio, Anna Campanati, Annamaria Offidani, Veronica Consales, Matteo Santoni, Giulia Ganzetti, Nicola Battelli, Francesca Barbisan and Michele Salati and has published in prestigious journals such as International Journal of Molecular Sciences, Breast Cancer Research and Treatment and Clinical & Experimental Immunology.

In The Last Decade

Giulia Sorgentoni

16 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giulia Sorgentoni Italy 10 78 74 72 70 61 16 268
Anja Steyls Netherlands 9 113 1.4× 92 1.2× 53 0.7× 43 0.6× 75 1.2× 13 390
María Carmen García-Macías Spain 9 72 0.9× 64 0.9× 53 0.7× 37 0.5× 39 0.6× 12 253
Giuseppina Vescio Italy 9 91 1.2× 100 1.4× 34 0.5× 42 0.6× 30 0.5× 26 307
Emma V. Morris United Kingdom 10 133 1.7× 144 1.9× 120 1.7× 40 0.6× 48 0.8× 14 374
Manabu Ono Japan 9 53 0.7× 85 1.1× 33 0.5× 147 2.1× 58 1.0× 18 321
Cuihong Wei Canada 8 147 1.9× 118 1.6× 57 0.8× 59 0.8× 39 0.6× 16 368
Dariusz Dziedzic Poland 10 110 1.4× 40 0.5× 23 0.3× 187 2.7× 33 0.5× 32 339
Nicholas C. Richardson United States 7 93 1.2× 63 0.9× 22 0.3× 16 0.2× 48 0.8× 16 253
G. Sébille France 3 151 1.9× 134 1.8× 59 0.8× 27 0.4× 16 0.3× 3 282

Countries citing papers authored by Giulia Sorgentoni

Since Specialization
Citations

This map shows the geographic impact of Giulia Sorgentoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Sorgentoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Sorgentoni more than expected).

Fields of papers citing papers by Giulia Sorgentoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Sorgentoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Sorgentoni. The network helps show where Giulia Sorgentoni may publish in the future.

Co-authorship network of co-authors of Giulia Sorgentoni

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Sorgentoni. A scholar is included among the top collaborators of Giulia Sorgentoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Sorgentoni. Giulia Sorgentoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Rizzo, Alessandro, Veronica Mollica, Sara Merler, et al.. (2022). Incidence of grade 3–4 adverse events, dose reduction, and treatment discontinuation in castration-resistant prostate cancer patients receiving PARP inhibitors: a meta-analysis. Expert Opinion on Drug Metabolism & Toxicology. 18(3). 235–240. 7 indexed citations
2.
Giuliani, Angelica, Simona Gaetani, Giulia Sorgentoni, et al.. (2021). Circulating Inflamma-miRs as Potential Biomarkers of Cognitive Impairment in Patients Affected by Alzheimer’s Disease. Frontiers in Aging Neuroscience. 13. 647015–647015. 31 indexed citations
3.
Santoni, Matteo, Alessia Cimadamore, Francesco Massari, et al.. (2021). Narrative review: predicting future molecular and clinical profiles of prostate cancer in the United States. Translational Andrology and Urology. 10(3). 1562–1568. 3 indexed citations
4.
Santoni, Matteo, Francesco Massari, Sergio Bracarda, et al.. (2021). Body Mass Index in Patients Treated with Cabozantinib for Advanced Renal Cell Carcinoma: A New Prognostic Factor?. Diagnostics. 11(1). 138–138. 11 indexed citations
5.
Rizzo, Alessandro, Sara Merler, Giulia Sorgentoni, et al.. (2021). Risk of cardiovascular toxicities and hypertension in nonmetastatic castration-resistant prostate cancer patients treated with novel hormonal agents: a systematic review and meta-analysis. Expert Opinion on Drug Metabolism & Toxicology. 17(10). 1237–1243. 15 indexed citations
6.
Occhipinti, Giulia, Emanuela Romagnoli, Matteo Santoni, et al.. (2020). Sequential or Concomitant Inhibition of Cyclin-Dependent Kinase 4/6 Before mTOR Pathway in Hormone-Positive HER2 Negative Breast Cancer: Biological Insights and Clinical Implications. Frontiers in Genetics. 11. 349–349. 8 indexed citations
7.
Aurilio, Gaetano, Francesco Piva, Matteo Santoni, et al.. (2019). The Role of Obesity in Renal Cell Carcinoma Patients: Clinical-Pathological Implications. International Journal of Molecular Sciences. 20(22). 5683–5683. 36 indexed citations
8.
Campanati, Anna, Ivan Bobyr, Giulia Sorgentoni, et al.. (2019). Mesenchymal stem cell profile in actinic keratosis and its modification after topical application of ingenol mebutate. Journal of the European Academy of Dermatology and Venereology. 34(3). e148–e149. 1 indexed citations
9.
Arena, Sabrina, Michele Salati, Giulia Sorgentoni, Francesca Barbisan, & Monia Orciani. (2018). Characterization of tumor-derived mesenchymal stem cells potentially differentiating into cancer-associated fibroblasts in lung cancer. Clinical & Translational Oncology. 20(12). 1582–1591. 24 indexed citations
10.
Campanati, Anna, Monia Orciani, Giulia Sorgentoni, et al.. (2018). Pathogenetic Characteristics of Mesenchymal Stem Cells in Hidradenitis Suppurativa. JAMA Dermatology. 154(10). 1184–1184. 19 indexed citations
11.
Campanati, Anna, Monia Orciani, Giulia Sorgentoni, et al.. (2018). Indirect co-cultures of healthy mesenchymal stem cells restore the physiological phenotypical profile of psoriatic mesenchymal stem cells. Clinical & Experimental Immunology. 193(2). 234–240. 29 indexed citations
12.
Campanati, Anna, Veronica Consales, Monia Orciani, et al.. (2017). Role of mesenchymal stem cells in the pathogenesis of psoriasis: current perspectives. PubMed. Volume 7. 73–85. 12 indexed citations
13.
Orciani, Monia, Giulia Sorgentoni, Olivieri Fabiola, et al.. (2017). Inflammation by Breast Implants and Adenocarcinoma: Not Always a Bad Company. Clinical Breast Cancer. 17(4). 286–292. 6 indexed citations
14.
Orciani, Monia, et al.. (2016). Effects of somatostatin and its analogues on progenitor mesenchymal cells isolated from human pituitary adenomas. Pituitary. 20(2). 251–260. 8 indexed citations
15.
Orciani, Monia, Giulia Sorgentoni, Matteo Torresetti, Roberto Di Primio, & Giovanni Di Benedetto. (2016). MSCs and inflammation: new insights into the potential association between ALCL and breast implants. Breast Cancer Research and Treatment. 156(1). 65–72. 20 indexed citations
16.
Campanati, Anna, Monia Orciani, Raffaella Lazzarini, et al.. (2016). TNF‐α inhibitors reduce the pathological Th1–Th17/Th2 imbalance in cutaneous mesenchymal stem cells of psoriasis patients. Experimental Dermatology. 26(4). 319–324. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026